Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy
暂无分享,去创建一个
A. Gnanasakthy | M. Manfredi | G. Avanzini | G. Zaccara | R. Michelucci | R. Mutani | C. Tassinari | B. Bergamasco | C. Loeb | F. Angeleri | E. Perucca | R. Zappoli | A. Baruzzi | G. Procaccianti | M. Gianelli | A. Iudice | J. Matthews | F. Pisani | R. Canger | A. Tartara | L. Cocito | C. Bianco | M. T. Faedda | R. Perri | O. Scarpino | J. Mumford | R. Mai | D. Binelli | E. Percucca | The Italian Study Group on Vigabatrin
[1] W. H. Butler,et al. Neuropathologic Findings in Patients Receiving Long-Term Vigabatrin Therapy for Chronic Intractable Epilepsy , 1991, Journal of child neurology.
[2] R. Heel,et al. Vigabatrin , 2012, Drugs.
[3] A. Ylinen,et al. Vigabatrin in drug‐resistant partial epilepsy , 1991, Neurology.
[4] R. Mattson,et al. Multicenter long‐term safety and efficacy study of vigabatrin for refractory complex partial seizures , 1991, Neurology.
[5] D. Bettucci,et al. Rational basis for the development of new antiepileptic drugs. , 1991, Epilepsy research. Supplement.
[6] M. Gianelli,et al. STUDIO MULTICENTRICO CON VIGABATRIN NELL'EPILESSIA FARMACORESISTENTE , 1990 .
[7] E. Perucca,et al. Vigabatrin in the treatment of epilepsy: a long-term follow-up study. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[8] C. Loeb,et al. Vigabatrin in complex partial seizures: a long-term study , 1989, Epilepsy Research.
[9] C. Remy,et al. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy. , 1989, British journal of clinical pharmacology.
[10] E. Perucca,et al. Effects of vigabatrin on evoked potentials in epileptic patients. , 1989, British journal of clinical pharmacology.
[11] D. Graham. Neuropathology of vigabatrin. , 1989, British journal of clinical pharmacology.
[12] E. Ben-Menachem,et al. The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients. , 1989, British journal of clinical pharmacology.
[13] M. Dam,et al. Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. , 1989, British journal of clinical pharmacology.
[14] A. Richens,et al. Interaction between vigabatrin and phenytoin. , 1989, British journal of clinical pharmacology.
[15] E. Mervaala,et al. Effect of vigabatrin on epilepsy in mentally retarded patients , 1988, Neurology.
[16] R. Michelucci,et al. Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy. , 1987, Archives of neurology.
[17] R. Mattson,et al. Vigabatrin for refractory complex partial seizures , 1987, Neurology.
[18] E. Perucca,et al. Vigabatrin in the Treatment of Epilepsy: A Double‐Blind, Placebo‐Controlled Study , 1986, Epilepsia.
[19] P. Loiseau,et al. Double‐Blind, Placebo‐Controlled Study of Vigabatrin (Gamma‐Vinyl GABA) in Drug‐Resistant Epilepsy , 1986, Epilepsia.
[20] M. Dam,et al. Long‐term study of gamma‐vinyl GABA in the treatment of epilepsy , 1985, Acta neurologica Scandinavica.
[21] M. Dam,et al. γ‐Vinyl GABA: A double‐blind placebo‐controlled trial in partial epilepsy , 1985 .
[22] B. Wilder,et al. Gamma-vinyl GABA: a new antiepileptic drug. , 1985, Clinical neuropharmacology.
[23] E. Rimmer,et al. DOUBLE-BLIND STUDY OF γ-VINYL GABA IN PATIENTS WITH REFRACTORY EPILEPSY , 1984, The Lancet.
[24] A. Richens,et al. Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy. , 1984, Lancet.